Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy
Abstract Background Compliance, palatability, gastrointestinal (GI) symptom, and treatment satisfaction patient- and observer-reported outcome (PRO, ObsRO) measures were developed/modified for patients with transfusion-dependent anemias or myelodysplastic syndrome (MDS) requiring iron chelation ther...
Main Authors: | Erica G. Horodniceanu, Vasudha Bal, Harman Dhatt, John A. Carter, Vicky Huang, Kathryn Lasch |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Health and Quality of Life Outcomes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12955-017-0702-0 |
Similar Items
-
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias
by: Ali T. Taher, et al.
Published: (2018-11-01) -
Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature
by: Mohamed Belmouhand, et al.
Published: (2021-07-01) -
Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findings
by: Emuella Flood, et al.
Published: (2017-09-01) -
Importance of iron chelation therapy
by: A. Varoğlu
Published: (2011-12-01) -
Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews
by: Rizio AA, et al.
Published: (2020-08-01)